The paper by Mah et al published in this edition of the Canadian Journal of the Neurological Sciences is an excellent illustration of how collaborative efforts across a clinical network are crucial in understanding rare diseases and improving standards of diagnosis and ultimately care. The paper presents the findings of the Canadian Paediatric Neurology Group which "was founded in 2005 as a collaborative effort to promote research and to enhance the clinical care of children with neuromuscular disease". This multidisciplinary group has representation across Canada. The work described here specifically addressed the issue of diagnosis in Duchenne muscular dystrophy over a ten-year-period during which diagnostic standards have changed significantly due to advances in molecular genetic technologies.
展开▼
